FindTrial
Sign In

The Prognostic Value of Nutritional and Immune Indices for Stage IB Non-Small Cell Lung Cancer Patients:Insights from a Retrospective Cohort Study

The Prognostic Value of Nutritional and Immune Indices for Stage IB Non-Small Cell Lung Cancer Patients:Insights from a Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101059
Enrollment
Unknown
Registered
2025-04-18
Start date
2025-04-02
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Stage IB Non-Small Cell Lung Cancer Patients:NA

Sponsors

West China Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Surgical patients with stage IB non-small cell lung cancer treated at the Department of Thoracic Surgery, West China Hospital of Sichuan University, from September 2005 to December 2014.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete clinical records, lacking perioperative (preoperative and postoperative) hematological/nutritional indicators or follow-up information 2. Patients with concomitant other malignancies that had received treatment prior to the diagnosis of non-small cell lung cancer 3. Patients who underwent robot-assisted thoracic surgery

Design outcomes

Primary

MeasureTime frame
Recurrence-free survival;Overall Survival;—

Countries

China

Contacts

Public ContactLunxu Liu

West China Hospital,Sichuan University

lunxu_liu@aliyun.com+86 189 8060 1525

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026